Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ffd5528fd07384d7b07ab484ed5b143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdaa64756184e715af6cb25ebc318917 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0057 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7135 |
filingDate |
2017-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f8f9a9e660b0b972cd8aad740463af6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53cd30b07c6259898d1dd491d53c0e92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a5e8bea05a19950ddcc3d133c16928b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3a31c9dd3f619df982e9d18f28994b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c60222e55af6d186982e874b0f3c487 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f719b22ca14c660b1e221d9973c3057e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff7914c13c1ff57102076ad9a4934d1c |
publicationDate |
2017-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017179053-A1 |
titleOfInvention |
Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative |
abstract |
An anti-myeloid-derived suppressor cells agent ("anti-MDSCs agent") and a bacteriochlorophyll derivative (hereinafter "Bchl-D) for use in combination therapy for cancer, wherein the anti-MDSC agent and the Bchl-D are administered sequentially and the administration of the Bchl-D is followed by photodynamic therapy (PDT) or vascular targeted PDT (VTP). |
priorityDate |
2016-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |